<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Spatial Genomics & AI | Cristea Lab</title>
    <link rel="stylesheet" href="../styles.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        .research-hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.9;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2.5rem;
            color: var(--primary-color);
            margin-bottom: 2rem;
            border-bottom: 3px solid var(--primary-color);
            padding-bottom: 0.5rem;
        }
        .project-card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--shadow);
            padding: 2.5rem;
            margin-bottom: 2rem;
            border-left: 5px solid var(--accent-color);
            transition: var(--transition);
        }
        .project-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.15);
        }
        .project-card h3 {
            font-size: 1.8rem;
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .project-card h4 {
            font-size: 1.3rem;
            color: var(--accent-color);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            font-size: 1.1rem;
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .project-details {
            background: var(--bg-light);
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        .project-details h5 {
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .methodology-list {
            list-style: none;
            padding: 0;
        }
        .methodology-list li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #eee;
        }
        .methodology-list li:last-child {
            border-bottom: none;
        }
        .methodology-list li::before {
            content: 'ðŸ”¬';
            margin-right: 0.5rem;
        }
        .impact-highlight {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid var(--secondary-color);
            margin: 2rem 0;
        }
        .impact-highlight h4 {
            color: var(--secondary-color);
            margin-bottom: 1rem;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--primary-color);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.9rem;
            font-weight: 500;
        }
        .clinical-trial-highlight {
            background: linear-gradient(135deg, #e3f2fd, #bbdefb);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid #2196f3;
            margin: 2rem 0;
        }
        .clinical-trial-highlight h4 {
            color: #1976d2;
            margin-bottom: 1rem;
        }
        .platform-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 2rem;
            margin: 2rem 0;
        }
        .platform-card {
            background: white;
            padding: 2rem;
            border-radius: 15px;
            box-shadow: var(--shadow);
            border-top: 4px solid var(--accent-color);
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">Computational Cancer Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../team.html" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>Spatial Genomics & AI</h1>
                <p>
                    Revolutionizing pancreatic cancer research through spatial modeling and analyses using clinical trial 
                    patient genomic and imaging data, integrating cutting-edge spatial transcriptomics with computational pathology.
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    Our spatial genomics research integrates high-resolution spatial transcriptomics, proteomics, and computational 
                    pathology to understand the complex tumor microenvironment in pancreatic cancer. We develop AI-powered analysis 
                    frameworks that can map cellular interactions, identify resistance mechanisms, and predict treatment responses 
                    at unprecedented spatial resolution.
                </div>
                
                <div class="impact-highlight">
                    <h4>Clinical Translation</h4>
                    <p>
                        This work directly impacts patient care by providing spatial biomarkers for treatment response prediction, 
                        identifying resistance mechanisms in KRAS inhibitor therapy, and developing personalized treatment strategies 
                        based on tumor microenvironment characteristics from ongoing clinical trials at Dana-Farber.
                    </p>
                </div>
            </div>

            <!-- Project A: Analysis Frameworks -->
            <div class="research-section">
                <h2>Project A: Spatial Transcriptomics Analysis Frameworks</h2>
                <div class="project-card">
                    <h3>CosMx Spatial Analysis Pipeline Development</h3>
                    <div class="project-description">
                        We are developing comprehensive computational frameworks for analyzing high-resolution spatial transcriptomics 
                        data from the Nanostring CosMx platform. Our pipeline integrates spatial gene expression analysis with 
                        computational pathology to provide multi-scale insights into tumor architecture.
                    </div>
                    
                    <div class="project-details">
                        <h5>Pipeline Components</h5>
                        <ul class="methodology-list">
                            <li>Quality control and normalization for CosMx spatial data</li>
                            <li>Cell segmentation and molecular assignment algorithms</li>
                            <li>Spatial neighborhood analysis and cellular interaction mapping</li>
                            <li>Integration with H&E histopathology images</li>
                            <li>Multi-resolution spatial analysis from subcellular to tissue-level</li>
                            <li>Statistical frameworks for spatial hypothesis testing</li>
                        </ul>
                    </div>

                    <div class="platform-grid">
                        <div class="platform-card">
                            <h4>Data Processing</h4>
                            <p>Advanced algorithms for handling the unique challenges of spatial transcriptomics data, including spatial autocorrelation, technical artifacts, and multi-scale analysis.</p>
                        </div>
                        <div class="platform-card">
                            <h4>Visualization Tools</h4>
                            <p>Interactive visualization platforms for exploring spatial gene expression patterns, cellular neighborhoods, and tissue architecture.</p>
                        </div>
                        <div class="platform-card">
                            <h4>Statistical Methods</h4>
                            <p>Novel statistical approaches for spatial differential expression analysis and identification of spatially variable genes.</p>
                        </div>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">CosMx Platform</span>
                        <span class="tech-tag">Spatial Transcriptomics</span>
                        <span class="tech-tag">Image Analysis</span>
                        <span class="tech-tag">Python/R Pipelines</span>
                        <span class="tech-tag">Statistical Modeling</span>
                    </div>
                </div>
            </div>

            <!-- Project B: Fibroblast Diversity -->
            <div class="research-section">
                <h2>Project B: Fibroblast Spatial Diversity in Pancreatic Cancer</h2>
                <div class="project-card">
                    <h3>Mapping Fibroblast Heterogeneity in Primary and Metastatic Disease</h3>
                    <div class="project-description">
                        We investigate the spatial organization and functional diversity of cancer-associated fibroblasts (CAFs) 
                        in primary pancreatic tumors and metastatic sites. This work reveals how fibroblast subtypes contribute 
                        to tumor progression and treatment resistance through spatial analysis of clinical samples.
                    </div>

                    <div class="project-details">
                        <h5>Research Objectives</h5>
                        <ul class="methodology-list">
                            <li>Characterize fibroblast subtypes using spatial transcriptomics</li>
                            <li>Map fibroblast-cancer cell interactions in tumor microenvironment</li>
                            <li>Compare primary vs. metastatic fibroblast spatial organization</li>
                            <li>Identify fibroblast signatures associated with treatment resistance</li>
                            <li>Develop spatial biomarkers for patient stratification</li>
                        </ul>
                    </div>

                    <div class="clinical-trial-highlight">
                        <h4>Clinical Relevance</h4>
                        <p>
                            Cancer-associated fibroblasts are key drivers of pancreatic cancer progression and treatment resistance. 
                            Our spatial analysis reveals how different fibroblast subtypes create therapeutic barriers and identifies 
                            opportunities for combination therapies targeting the tumor microenvironment.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Key Findings</h5>
                        <p>
                            Our analysis has identified distinct spatial patterns of fibroblast organization that correlate with 
                            patient outcomes. Specific fibroblast subtypes form protective niches around cancer cells, contributing 
                            to drug resistance and immune evasion. These findings are informing new therapeutic strategies.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Cancer-Associated Fibroblasts</span>
                        <span class="tech-tag">Spatial Analysis</span>
                        <span class="tech-tag">Tumor Microenvironment</span>
                        <span class="tech-tag">Clinical Samples</span>
                        <span class="tech-tag">Biomarker Discovery</span>
                    </div>
                </div>
            </div>

            <!-- Project C: Collagen-Stroma Analysis -->
            <div class="research-section">
                <h2>Project C: Spatial Analysis of Collagen-Stroma Associations</h2>
                <div class="project-card">
                    <h3>Extracellular Matrix Architecture in Pancreatic Cancer</h3>
                    <div class="project-description">
                        We develop novel computational methods to analyze the spatial relationship between collagen deposition, 
                        stromal cell organization, and cancer cell invasion patterns. This work combines imaging mass cytometry 
                        with spatial transcriptomics to understand how ECM remodeling drives tumor progression.
                    </div>

                    <div class="project-details">
                        <h5>Analytical Approaches</h5>
                        <ul class="methodology-list">
                            <li>Multi-modal integration of spatial transcriptomics and proteomics</li>
                            <li>Collagen fiber orientation and density analysis</li>
                            <li>Spatial correlation analysis between ECM and cellular components</li>
                            <li>Machine learning models for ECM pattern classification</li>
                            <li>Mechanistic modeling of tumor-stroma interactions</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Clinical Applications</h5>
                        <p>
                            The dense stromal environment of pancreatic cancer creates barriers to drug delivery and promotes 
                            resistance. Our spatial analysis identifies ECM patterns that predict treatment response and reveals 
                            opportunities for stroma-targeted therapies to improve drug penetration and efficacy.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Extracellular Matrix</span>
                        <span class="tech-tag">Collagen Analysis</span>
                        <span class="tech-tag">Stromal Biology</span>
                        <span class="tech-tag">Multi-modal Integration</span>
                        <span class="tech-tag">Drug Delivery</span>
                    </div>
                </div>
            </div>

            <!-- Project D: KRAS Resistance -->
            <div class="research-section">
                <h2>Project D: Spatial Features of KRAS Inhibition Resistance</h2>
                <div class="project-card">
                    <h3>Understanding Resistance Mechanisms Through Spatial Analysis</h3>
                    <div class="project-description">
                        In collaboration with Revolution Medicines, we analyze spatial features of resistance to KRAS inhibition 
                        in pancreatic cancer using data from the RMC-6236 clinical trial. This work identifies spatial biomarkers 
                        of resistance and maps how resistant cell populations emerge and spread within tumors.
                    </div>

                    <div class="clinical-trial-highlight">
                        <h4>RMC-6236 Clinical Trial</h4>
                        <p>
                            We are analyzing spatial transcriptomics and proteomics data from patients treated with RMC-6236, 
                            a next-generation KRAS inhibitor. This represents one of the first comprehensive spatial analyses 
                            of KRAS inhibitor resistance in clinical samples, providing unprecedented insights into resistance mechanisms.
                        </p>
                    </div>

                    <div class="project-details">
                        <h5>Resistance Analysis Framework</h5>
                        <ul class="methodology-list">
                            <li>Pre-treatment and post-treatment spatial profiling</li>
                            <li>Identification of resistant cell populations and their spatial distribution</li>
                            <li>Analysis of cell-cell communication networks in resistance</li>
                            <li>Spatial mapping of compensatory signaling pathways</li>
                            <li>Development of predictive models for resistance emergence</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Therapeutic Implications</h5>
                        <p>
                            Our spatial analysis reveals that resistance to KRAS inhibition often emerges in specific 
                            microenvironmental niches. Understanding the spatial patterns of resistance will inform 
                            combination therapy strategies and help predict which patients are most likely to benefit 
                            from KRAS-targeted treatments.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">KRAS Inhibitors</span>
                        <span class="tech-tag">Drug Resistance</span>
                        <span class="tech-tag">Clinical Trial Data</span>
                        <span class="tech-tag">Spatial Biomarkers</span>
                        <span class="tech-tag">Revolution Medicines</span>
                    </div>
                </div>
            </div>

            <!-- Project E: High-plex Protein Profiling -->
            <div class="research-section">
                <h2>Project E: High-plex Protein Profiling in PDAC</h2>
                <div class="project-card">
                    <h3>Spatial Proteomics Analysis Framework</h3>
                    <div class="project-description">
                        We develop comprehensive frameworks for analyzing high-plex spatial proteomics data in pancreatic 
                        ductal adenocarcinoma (PDAC). This work integrates imaging mass cytometry with spatial transcriptomics 
                        to provide multi-dimensional views of the tumor microenvironment at protein and RNA levels.
                    </div>

                    <div class="project-details">
                        <h5>Proteomics Pipeline</h5>
                        <ul class="methodology-list">
                            <li>High-dimensional protein expression analysis in spatial context</li>
                            <li>Cell phenotyping and functional state identification</li>
                            <li>Protein-protein interaction network analysis</li>
                            <li>Integration with spatial transcriptomics data</li>
                            <li>Identification of spatial protein biomarkers</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Multi-omics Integration</h5>
                        <p>
                            By combining spatial proteomics with transcriptomics, we can identify post-translational 
                            modifications, protein localization patterns, and functional protein complexes that are 
                            not detectable through transcriptomics alone. This provides a more complete picture of 
                            cellular function in the tumor microenvironment.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Spatial Proteomics</span>
                        <span class="tech-tag">Imaging Mass Cytometry</span>
                        <span class="tech-tag">Multi-omics Integration</span>
                        <span class="tech-tag">Protein Networks</span>
                        <span class="tech-tag">High-plex Analysis</span>
                    </div>
                </div>
            </div>

            <!-- Project F: Computational Pathology -->
            <div class="research-section">
                <h2>Project F: Foundation Models in Computational Pathology</h2>
                <div class="project-card">
                    <h3>Counterfactual Perturbations of Histopathology Images</h3>
                    <div class="project-description">
                        We implement cutting-edge foundation models for computational pathology to generate counterfactual 
                        perturbations of histopathology images. This work allows us to simulate treatment effects and 
                        understand how therapeutic interventions change tissue architecture.
                    </div>

                    <div class="project-details">
                        <h5>Foundation Model Applications</h5>
                        <ul class="methodology-list">
                            <li>Pre-trained histopathology foundation models (e.g., PathLDM, HistoGen)</li>
                            <li>Counterfactual image generation for treatment simulation</li>
                            <li>Integration with spatial transcriptomics data</li>
                            <li>Morphological feature extraction and analysis</li>
                            <li>Automated pathology assessment and scoring</li>
                        </ul>
                    </div>

                    <div class="impact-highlight">
                        <h4>Revolutionary Approach</h4>
                        <p>
                            This work represents a new paradigm in computational pathology where we can generate synthetic 
                            images showing how tissues might respond to treatments. This capability will accelerate drug 
                            development and help predict treatment responses before therapy initiation.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">Foundation Models</span>
                        <span class="tech-tag">Computational Pathology</span>
                        <span class="tech-tag">Counterfactual Analysis</span>
                        <span class="tech-tag">Image Generation</span>
                        <span class="tech-tag">Treatment Simulation</span>
                    </div>
                </div>
            </div>

            <!-- Key Publications & Software -->
            <div class="research-section">
                <h2>Publications & Software</h2>
                <div class="project-card">
                    <h3>Key Outputs</h3>
                    <div class="project-details">
                        <h5>Manuscripts in Preparation</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Spatial transcriptomics analysis framework</strong> - Comprehensive pipeline for CosMx data analysis (2025)</li>
                            <li><strong>Fibroblast spatial diversity in pancreatic cancer</strong> - Primary vs. metastatic analysis (2025)</li>
                            <li><strong>KRAS inhibitor resistance spatial signatures</strong> - RMC-6236 clinical trial analysis (2025)</li>
                            <li><strong>Computational pathology foundation models</strong> - Counterfactual perturbation methods (2025)</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Software & Tools</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>CosMx Analysis Suite</strong> - Comprehensive spatial transcriptomics pipeline</li>
                            <li><strong>Spatial Biomarker Toolkit</strong> - Tools for spatial biomarker discovery and validation</li>
                            <li><strong>Multi-modal Spatial Integration Platform</strong> - Framework for combining spatial omics data</li>
                            <li><strong>PathologyFoundation Toolkit</strong> - Counterfactual image generation tools</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Future Directions -->
            <div class="research-section">
                <h2>Future Directions</h2>
                <div class="impact-highlight">
                    <h4>Integrative Spatial LLMs</h4>
                    <p>
                        We are developing the next generation of spatial analysis tools that integrate LLM approaches with 
                        spatial multi-omics data. This will enable predictive spatial models of pancreatic cancer response 
                        to various treatments, revolutionizing personalized treatment selection by providing spatial predictions 
                        of treatment efficacy before therapy administration.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>Computational Cancer Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script.js"></script>
</body>
</html>